Chevron: Analysts' Upgrades, Downgrades

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Cooper Industries (CBE) upgraded at Morgan Stanley from Equal-weight to Overweight. $50 price target. Stock trades at a 20% discount to its peers, even following a strong run.

Royal Caribbean (RCL) upgraded at Wells to Outperform. New ships will improve mix yields and the company should realize cost leverage.

STOCK COMMENTS / EPS CHANGES

Arch Coal (ACI) estimates raised at FBR through 2010. Company is seeing a higher sales volume and lower costs. Outperform rating and $31 price target.

Boston Scientific (BSX) numbers lowered at Goldman. Shares now seen reaching $9.25. Estimates also cut, to reflect lower stent sales and higher operating costs. Neutral rating.

Covidien (COV) estimates, target boosted at Morgan Stanley. Shares of COV now seen reaching $48. Estimates also increased, to reflect generic Actiq sales and better currency trends. Overweight rating.

Chevron (CVX) estimates raised at UBS through 2010. Company is seeing lower upstream costs. Buy rating and $89 price target.

Chevron (CVX) price target, estimates higher at Barclays. CVX price target raised to $98 from $96. 2009 and 2010 EPS estimates lifted to $5.05 from $4.50 and to $8.15 from $7.60, respectively. Reiterate Overweight rating.

Dick's Sporting Goods (DKS) numbers raised at Goldman. Shares now seen reaching $26. Estimates also boosted, to reflect better sales visibility. Neutral rating.

Eastman Chemical (EMN) price target boosted at Barclays to $50 from $46 following strong 3Q numbers. 2009 EPS estimate lifted to $3.39 from $3.02, 2010 introduced at $4.14. Maintain Equal Weight rating.